GlaxoSmithKline's London offices will be assessing the impact of the Chinese probe on its drug operations. Photo: Reuters
GlaxoSmithKline's London offices will be assessing the impact of the Chinese probe on its drug operations. Photo: Reuters

Risk of UK and US action hangs over GSK

With listings in London and New York, the drug giant could face further investigations if its executives are convicted of bribery on the mainland

Topic |   GlaxoSmithKline
GlaxoSmithKline's London offices will be assessing the impact of the Chinese probe on its drug operations. Photo: Reuters
GlaxoSmithKline's London offices will be assessing the impact of the Chinese probe on its drug operations. Photo: Reuters
READ FULL ARTICLE